(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are NEW SOURCES ENERGY, ENSURGE MICROPOWER, and INCLUSIO SA/NV.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NEW SOURCES ENERGY (NSE.AS) | 0.04 | 25% | 2024-02-26 12:03:02 |
| ENSURGE MICROPOWER (ENSU.OL) | 0.35 | 20.69% | 2024-02-26 12:26:00 |
| INCLUSIO SA/NV (INCLU.BR) | 14.00 | 14.81% | 2024-02-26 12:20:22 |
| HYBRID SOFTWARE GR (HYSG.BR) | 3.16 | 9.09% | 2024-02-26 12:20:09 |
| ABIVAX (ABVX.PA) | 13.20 | 8.2% | 2024-02-26 12:44:41 |
| VERIMATRIX (VMX.PA) | 0.56 | 7.92% | 2024-02-26 13:24:24 |
| BELYSSE GROUP (BELYS.BR) | 0.70 | 6.4% | 2024-02-26 12:05:12 |
| COLRUYT (COLR.BR) | 42.94 | 6.37% | 2024-02-26 12:05:37 |
| ADOCIA (ADOC.PA) | 10.46 | 6.3% | 2024-02-26 12:44:57 |
| LUMIBIRD (LBIRD.PA) | 14.22 | 6.12% | 2024-02-26 13:05:55 |
The three biggest losers today are TERACT, BERGENBIO, and NYXOAH.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| TERACT (TRACT.PA) | 0.80 | -18.24% | 2024-02-26 13:23:35 |
| BERGENBIO (BGBIO.OL) | 0.20 | -12.89% | 2024-02-26 12:25:07 |
| NYXOAH (NYXH.BR) | 14.00 | -12.19% | 2024-02-26 12:20:57 |
| BANK OF IRELAND GP (BIRG.IR) | 8.07 | -11.32% | 2024-02-26 12:22:20 |
| PROACTIS SA (PROAC.PA) | 0.06 | -8.4% | 2024-02-26 13:21:39 |
| METABOLIC EXPLORER (METEX.PA) | 0.37 | -8.24% | 2024-02-26 13:20:22 |
| MAAT PHARMA (MAAT.PA) | 8.06 | -7.57% | 2024-02-26 13:06:02 |
| ATOS (ATO.PA) | 2.24 | -6.98% | 2024-02-26 12:45:55 |
| UNIFIEDPOST GROUP (UPG.BR) | 3.12 | -6.88% | 2024-02-26 12:21:57 |
| ARAMIS GROUP (ARAMI.PA) | 3.55 | -6.82% | 2024-02-26 12:45:39 |
Winners today
1. NEW SOURCES ENERGY (NSE.AS)
25% Price Change
New Sources Energy N.V. develops, operates, exploits, and invests in projects that generates electricity using renewable energy sources. The company was formerly known as Management Share NV and changed its name to New Sources Energy N.V. in July 2011. New Sources Energy N.V. is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with NEW SOURCES ENERGY jumping 25% to €0.04 on Monday, following the last session’s downward trend. AEX-Index slid 0.25% to €852.87, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Yearly Top and Bottom Value
NEW SOURCES ENERGY’s stock is valued at €0.04 at 21:40 EST, way below its 52-week high of €0.06 and way higher than its 52-week low of €0.01.
Moving Average
NEW SOURCES ENERGY’s value is higher than its 50-day moving average of €0.04 and way higher than its 200-day moving average of €0.03.
More news about NEW SOURCES ENERGY.
2. ENSURGE MICROPOWER (ENSU.OL)
20.69% Price Change
Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 20.69% to €0.35 on Monday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.12% to €1,262.31, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.5.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ENSURGE MICROPOWER’s EBITDA is -150.46.
More news about ENSURGE MICROPOWER.
3. INCLUSIO SA/NV (INCLU.BR)
14.81% Price Change
Inclusio SA operates as a real estate company in Belgium. It focuses on affordable rental housing, housing for disabled, and social infrastructures. Inclusio SA was incorporated in 2011 and is based in Brussels, Belgium.
BEL 20 ended the session with INCLUSIO SA/NV rising 14.81% to €14.00 on Monday, after four consecutive sessions in a row of losses. BEL 20 dropped 0.6% to €3,685.19, after three successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, INCLUSIO SA/NV has a trailing twelve months EPS of €2.37.
PE Ratio
INCLUSIO SA/NV has a trailing twelve months price to earnings ratio of 5.91. Meaning, the purchaser of the share is investing €5.91 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.65%.
Volatility
INCLUSIO SA/NV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.08%, a negative 0.05%, and a positive 1.07%.
INCLUSIO SA/NV’s highest amplitude of average volatility was 1.08% (last week), 0.96% (last month), and 1.07% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.2%, now sitting on 12.4M for the twelve trailing months.
More news about INCLUSIO SA/NV.
4. HYBRID SOFTWARE GR (HYSG.BR)
9.09% Price Change
Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom.
BEL 20 ended the session with HYBRID SOFTWARE GR jumping 9.09% to €3.16 on Monday while BEL 20 dropped 0.6% to €3,685.19.
Earnings Per Share
As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.02.
PE Ratio
HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 158. Meaning, the purchaser of the share is investing €158 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.54%.
More news about HYBRID SOFTWARE GR.
5. ABIVAX (ABVX.PA)
8.2% Price Change
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
CAC 40 ended the session with ABIVAX jumping 8.2% to €13.20 on Monday while CAC 40 slid 0.46% to €7,929.82.
Earnings Per Share
As for profitability, ABIVAX has a trailing twelve months EPS of €-2.43.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -211.42%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABIVAX’s stock is considered to be oversold (<=20).
Moving Average
ABIVAX’s worth is way higher than its 50-day moving average of €9.53 and below its 200-day moving average of €13.58.
Volatility
ABIVAX’s last week, last month’s, and last quarter’s current intraday variation average was 1.28%, 0.26%, and 2.20%.
ABIVAX’s highest amplitude of average volatility was 3.72% (last week), 2.11% (last month), and 2.20% (last quarter).
More news about ABIVAX.
6. VERIMATRIX (VMX.PA)
7.92% Price Change
Verimatrix SA provides security solutions that protect digital content, applications, and devices worldwide. It offers anti-piracy products, including Streamkeeper Pro, which safeguards the OTT content distribution ecosystem by disrupting pirate revenue streams; Streamkeeper Multi-DRM that offers secure content on any screen or platform; Streamkeeper Watermarking, which protects content with invisible client and server-side watermarking that can detect piracy; and Video Content Authority System (VCAS) for evolving networks. The company also provides threat defense solutions, such as App Shield that secures android and iOS apps; Code Shield, which secures code with an enterprise-grade security toolkit; Key Shield, that protects algorithm and builds secure cryptographic architectures; and Extended Threat Defense, a cybersecurity solution. It offers security solutions for various markets comprising automotive, e-sports and gaming, financial services, healthcare, Internet of Things, live sports, media and entertainment, pay TV, and streaming media, as well as for content owners. The company was formerly known as Inside Secure S.A. and changed its name to Verimatrix SA in July 2017. Verimatrix SA was incorporated in 1995 and is based in Meyreuil, France.
CAC 40 ended the session with VERIMATRIX rising 7.92% to €0.56 on Monday while CAC 40 slid 0.46% to €7,929.82.
Earnings Per Share
As for profitability, VERIMATRIX has a trailing twelve months EPS of €-0.19.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.99%.
Volatility
VERIMATRIX’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a positive 1.73%, and a positive 2.82%.
VERIMATRIX’s highest amplitude of average volatility was 3.35% (last week), 3.94% (last month), and 2.82% (last quarter).
Moving Average
VERIMATRIX’s worth is below its 50-day moving average of €0.60 and way under its 200-day moving average of €0.68.
Yearly Top and Bottom Value
VERIMATRIX’s stock is valued at €0.56 at 21:40 EST, way under its 52-week high of €0.94 and way above its 52-week low of €0.40.
More news about VERIMATRIX.
7. BELYSSE GROUP (BELYS.BR)
6.4% Price Change
Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.
BEL 20 ended the session with BELYSSE GROUP jumping 6.4% to €0.70 on Monday while BEL 20 slid 0.6% to €3,685.19.
Earnings Per Share
As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.45.
Volatility
BELYSSE GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.02%, a positive 0.01%, and a positive 3.69%.
BELYSSE GROUP’s highest amplitude of average volatility was 2.40% (last week), 3.99% (last month), and 3.69% (last quarter).
More news about BELYSSE GROUP.
8. COLRUYT (COLR.BR)
6.37% Price Change
Colruyt Group N.V., together with its subsidiaries, engages in the retail, wholesale, food service, and other activities in Belgium, France, Luxembourg, and internationally. It operates through three segments: Retail, Wholesale and Foodservice, and Other Activities. The company provides groceries, fresh products, dry products, and frozen and non-food products; and operates CNG, hydrogen filling, and charging stations. It also provides printing and document management solutions; and develops, constructs, operates, maintains, and finances wind energy projects. The company offers its products and services under the Bike Republic, Bio-Planet, Boni Selection, Collect&Go, Colruyt Group Academy, Colruyt Lowest Prices, Colruyt Prix Qualité, Cru, DATS 24, Dreambaby, Dreamland, Everyday, Graindor, Kangourou, Okay, Spar Colruyt Group, Xtra, Jims, Newpharma, The Fashion Society, Codifrance, Colex, Solucious, Spar For You, and Symeta Hybrid brands. It provides its products and services to wholesalers, commercial customers, and affiliated independent merchants, as well as schools, care homes, the hospitality sector, etc. The company was formerly known as Etn. Fr. Colruyt NV and changed its name to Colruyt Group N.V. in October 2023. The company was founded in 1928 and is headquartered in Halle, Belgium.
BEL 20 ended the session with COLRUYT rising 6.37% to €42.94 on Monday, after two sequential sessions in a row of losses. BEL 20 slid 0.6% to €3,685.19, after three consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, COLRUYT has a trailing twelve months EPS of €7.86.
PE Ratio
COLRUYT has a trailing twelve months price to earnings ratio of 5.46. Meaning, the purchaser of the share is investing €5.46 for every euro of annual earnings.
Volume
Today’s last reported volume for COLRUYT is 68779 which is 26.25% below its average volume of 93271.
Volatility
COLRUYT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.12%, a negative 0.17%, and a positive 0.89%.
COLRUYT’s highest amplitude of average volatility was 0.38% (last week), 0.80% (last month), and 0.89% (last quarter).
More news about COLRUYT.
9. ADOCIA (ADOC.PA)
6.3% Price Change
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
CAC 40 ended the session with ADOCIA rising 6.3% to €10.46 on Monday, following the last session’s downward trend. CAC 40 slid 0.46% to €7,929.82, after four consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-2.5.
More news about ADOCIA.
10. LUMIBIRD (LBIRD.PA)
6.12% Price Change
Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two segments, Photonics and Medical. The company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, Laser rangefinder and LiDAR wind doppler LiDAR, medical and ophthalmological equipment. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The company was incorporated in 1970 and is headquartered in Lannion, France.
CAC 40 ended the session with LUMIBIRD rising 6.12% to €14.22 on Monday, following the last session’s upward trend. CAC 40 fell 0.46% to €7,929.82, after four consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, LUMIBIRD has a trailing twelve months EPS of €0.45.
PE Ratio
LUMIBIRD has a trailing twelve months price to earnings ratio of 31.6. Meaning, the purchaser of the share is investing €31.6 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.68%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LUMIBIRD’s stock is considered to be oversold (<=20).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.25%.
More news about LUMIBIRD.
Losers Today
1. TERACT (TRACT.PA)
-18.24% Price Change
Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.
CAC 40 ended the session with TERACT falling 18.24% to €0.80 on Monday while CAC 40 slid 0.46% to €7,929.82.
Earnings Per Share
As for profitability, TERACT has a trailing twelve months EPS of €0.62.
PE Ratio
TERACT has a trailing twelve months price to earnings ratio of 1.29. Meaning, the purchaser of the share is investing €1.29 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.98%.
More news about TERACT.
2. BERGENBIO (BGBIO.OL)
-12.89% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 12.89% to €0.20 on Monday while Oslo Børs Benchmark Index_GI rose 0.12% to €1,262.31.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-0.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.
More news about BERGENBIO.
3. NYXOAH (NYXH.BR)
-12.19% Price Change
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with NYXOAH falling 12.19% to €14.00 on Monday while BEL 20 dropped 0.6% to €3,685.19.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
More news about NYXOAH.
4. BANK OF IRELAND GP (BIRG.IR)
-11.32% Price Change
Bank of Ireland Group plc provides various banking and financial products and services. It provides current and savings accounts, and business deposits and accounts; personal, car, home improvement, graduate, motor finance, and student loans, as well as overdrafts; and business and farming loans, BREXIT loans, invoice finance, hire purchase, and leasing services. The company also offers international payments and credit cards; protection overview, mortgage protection, life cover, specified illness cover, income protection, protection for individuals, and protection for families; pensions and investments, foreign exchange, and treasury deposits and services; personal products; private banking services; and leveraged acquisition and property finance. In addition, it provides home, car, travel, and life insurance products. The company was founded in 1783 and is headquartered in Dublin, Ireland.
ISEQ All Share ended the session with BANK OF IRELAND GP falling 11.32% to €8.07 on Monday while ISEQ All Share fell 2.13% to €9,454.75.
Earnings Per Share
As for profitability, BANK OF IRELAND GP has a trailing twelve months EPS of €1.27.
PE Ratio
BANK OF IRELAND GP has a trailing twelve months price to earnings ratio of 6.35. Meaning, the purchaser of the share is investing €6.35 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.05%.
Volatility
BANK OF IRELAND GP’s last week, last month’s, and last quarter’s current intraday variation average was 1.68%, 0.48%, and 1.41%.
BANK OF IRELAND GP’s highest amplitude of average volatility was 2.15% (last week), 1.51% (last month), and 1.41% (last quarter).
More news about BANK OF IRELAND GP.
5. PROACTIS SA (PROAC.PA)
-8.4% Price Change
Proactis SA provides source-to-pay software solution. It operates software platform that will give control over business spend. It also offers procurement solutions that provide purchasing professionals with the tools they need for purchasing process for routine goods and services, capital goods, and major projects. In addition, it offers invoice capture services, system administration, supplier onboarding, and tail spent management services. Further, Its solutions integrate with various ERP or financial systems. The company was formerly known as HUBWOO and changed its name to Proactis SA in January 2019. The company is based in Suresnes, France. Proactis SA operates as a subsidiary of Proactis Euro Hedgeco Limited.
CAC 40 ended the session with PROACTIS SA sliding 8.4% to €0.06 on Monday, following the last session’s upward trend. CAC 40 dropped 0.46% to €7,929.82, after four sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, PROACTIS SA has a trailing twelve months EPS of €-0.01.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.88%.
Yearly Top and Bottom Value
PROACTIS SA’s stock is valued at €0.06 at 21:40 EST, way below its 52-week high of €0.13 and way higher than its 52-week low of €0.04.
More news about PROACTIS SA.
6. METABOLIC EXPLORER (METEX.PA)
-8.24% Price Change
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
CAC 40 ended the session with METABOLIC EXPLORER sliding 8.24% to €0.37 on Monday, after two successive sessions in a row of gains. CAC 40 dropped 0.46% to €7,929.82, after four consecutive sessions in a row of gains, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.
More news about METABOLIC EXPLORER.
7. MAAT PHARMA (MAAT.PA)
-7.57% Price Change
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
CAC 40 ended the session with MAAT PHARMA dropping 7.57% to €8.06 on Monday, after two consecutive sessions in a row of gains. CAC 40 dropped 0.46% to €7,929.82, after four successive sessions in a row of gains, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, MAAT PHARMA has a trailing twelve months EPS of €-1.4.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.11%.
Volume
Today’s last reported volume for MAAT PHARMA is 1902 which is 25.21% above its average volume of 1519.
More news about MAAT PHARMA.
8. ATOS (ATO.PA)
-6.98% Price Change
Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.
CAC 40 ended the session with ATOS falling 6.98% to €2.24 on Monday, after three successive sessions in a row of gains. CAC 40 fell 0.46% to €7,929.82, after four sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, ATOS has a trailing twelve months EPS of €-10.01.
Volatility
ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.56%, a negative 3.64%, and a positive 5.08%.
ATOS’s highest amplitude of average volatility was 5.03% (last week), 5.22% (last month), and 5.08% (last quarter).
Volume
Today’s last reported volume for ATOS is 1069800 which is 54.25% below its average volume of 2338400.
More news about ATOS.
9. UNIFIEDPOST GROUP (UPG.BR)
-6.88% Price Change
UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.
BEL 20 ended the session with UNIFIEDPOST GROUP falling 6.88% to €3.12 on Monday while BEL 20 fell 0.6% to €3,685.19.
Earnings Per Share
As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-1.32.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.78%.
Moving Average
UNIFIEDPOST GROUP’s worth is way higher than its 50-day moving average of €2.84 and higher than its 200-day moving average of €3.04.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UNIFIEDPOST GROUP’s stock is considered to be oversold (<=20).
More news about UNIFIEDPOST GROUP.
10. ARAMIS GROUP (ARAMI.PA)
-6.82% Price Change
Aramis Group SAS engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Belgium, Austria, Italy, and Spain. It operates under the Aramisauto, Cardoen, Clicars, CarSupermarket, Onlinecars, and Brumbrum brands. The company was founded in 2001 and is based in Arcueil, France. Aramis Group SAS operates as a subsidiary of Stellantis Auto SAS.
CAC 40 ended the session with ARAMIS GROUP falling 6.82% to €3.55 on Monday while CAC 40 slid 0.46% to €7,929.82.
Earnings Per Share
As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-0.39.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARAMIS GROUP’s stock is considered to be overbought (>=80).
More news about ARAMIS GROUP.
Stay up to date with our winners and losers daily report
